Janney Montgomery Scott LLC Anavex Life Sciences Corp. Transaction History

Janney Montgomery Scott LLC

  • $33.6 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 26, 2023
BUY
$7.66 - $9.5 $196,716 - $243,969
25,681 New
25,681 $209,000
Q4 2022

Feb 01, 2023
BUY
$7.65 - $14.43 $104,032 - $196,233
13,599 Added 130.0%
24,060 $223,000
Q3 2022

Oct 25, 2022
BUY
$8.9 - $12.86 $93,102 - $134,528
10,461 New
10,461 $108,000

Others Institutions Holding AVXL

# of Institutions
159
Shares Held
31.6M
Call Options Held
910K
Put Options Held
1.35M
View Full List

About ANAVEX LIFE SCIENCES CORP.

AVXL Quotes by TradingView
  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $352M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email